DCEM1
DCEM1 binds to heat shock protein 60 (HSP60) and inhibits the interaction of HSP60 with ClpP, thereby blocking the mitochondrial unfolded protein response. DCEM1 inhibits β-catenin expression and ATP production in PC-3 and TKO cells. DCEM1 can be used in prostate cancer research[1][2].
Product Specifications
CAS Number
878949-21-4
UNSPSC
12352005
Target
HSP; β-catenin
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.31
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCOC1=CC(CNCC2=NC3=C(N2)C=CC=C3)=CC=C1OCC4=CC=CS4
Molecular Formula
C22H23N3O2S
Molecular Weight
393.50
References & Citations
[1]Dhyan C, et al. Methods for disrupting mitochondrial unfolded protein response. WO2022103897. WIPO (PCT) . 2021-11-10.|[2]Woytash JA, et al. Mitochondrial unfolded protein response-dependent β-catenin signaling promotes neuroendocrine prostate cancer. Oncogene. 2025 Apr;44 (12) :820-834.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2928111-01 20 µg
Recombinant Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
Sign In for Pricing
View Details orb2928111-02 100 µg
Recombinant Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)
Sign In for Pricing
View Details